Levofloxacina Reiwa Healthcare

Levofloxacin, the active ingredient in Levofloxacina Reiwa Healthcare, is a fluoroquinolone antibiotic presented as an intravenous solution for intravenous use. It treats a range of serious bacterial infections in adults, including pneumonia, urinary tract and intra‑abdominal infections.

GNH USA supplies Levofloxacina Reiwa Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Levofloxacin is a broad‑spectrum fluoroquinolone used to treat bacterial infections in several organ systems. - Community‑acquired pneumonia: achieves rapid bacterial eradication and clinical recovery. - Hospital‑acquired pneumonia: provides effective coverage against resistant pathogens. - Complicated urinary tract infections: clears infection and prevents recurrence. - Complicated intra‑abdominal infections: resolves polymicrobial infection after surgical source control. - Skin and soft tissue infections: eliminates causative bacteria and promotes healing.

Levofloxacina Reiwa Healthcare may cause a variety of adverse reactions.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: loose stools, sometimes watery. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness. - Rash: mild skin erythema. - Elevated liver enzymes: transient laboratory changes.

Serious or Rare Side Effects: - Tendon rupture: especially Achilles tendon, may occur without warning. - QT interval prolongation: can precipitate cardiac arrhythmias. - Clostridioides difficile infection: severe colitis risk. - Severe hypersensitivity: anaphylaxis or Stevens‑Johnson syndrome. - Hepatic dysfunction: jaundice or hepatitis. - Peripheral neuropathy: numbness or tingling sensations.

Levofloxacina Reiwa Healthcare requires careful patient assessment before use. - Renal function: adjust dosing in patients with impaired clearance. - History of tendon disorders: avoid in individuals with prior tendon injury. - Cardiac risk: monitor QT interval in patients with known prolongation. - Concomitant CNS disorders: use caution in patients prone to seizures. - Pregnancy: category C, weigh benefits against potential fetal risk. - Store at ambient temperature: keep in original container, protect from light and moisture.

Levofloxacina Reiwa Healthcare can interact with several medicines.

Major Interactions (Avoid): - Antacids containing magnesium or aluminum: reduce absorption. - Warfarin: may increase anticoagulant effect. - Systemic corticosteroids: heightened risk of tendon rupture. - Theophylline: increased plasma concentrations. - Cyclosporine: elevated levels may cause toxicity.

Moderate Interactions (Monitor Closely): - NSAIDs: additive risk of CNS stimulation. - Oral hypoglycemics: may enhance glucose‑lowering effect. - Diuretics: potential for electrolyte disturbances. - QT‑prolonging agents: monitor cardiac rhythm. - Insulin: possible hypoglycaemia augmentation.